U.S. pharma large copyright scrapped two experimental weight loss pills final yr—a at the time-each day tablet, lotiglipron, because of elevated liver enzymes as well as a 2 times-every day pill, danuglipron, on account of potent Unintended effects—but CEO Albert Bourla has said the company is determined to “Enjoy and earn” from the being o